Teladoc Health (NYSE:TDOC) Stock Price Down 5.8%

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) dropped 5.8% on Friday . The stock traded as low as $8.65 and last traded at $8.65. Approximately 2,295,717 shares traded hands during mid-day trading, a decline of 58% from the average daily volume of 5,526,234 shares. The stock had previously closed at $9.18.

Analyst Upgrades and Downgrades

A number of analysts have commented on TDOC shares. Jefferies Financial Group lifted their target price on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a "hold" rating in a report on Tuesday. Oppenheimer decreased their price objective on Teladoc Health from $21.00 to $17.00 and set an "outperform" rating for the company in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft cut their target price on Teladoc Health from $15.00 to $10.00 and set a "hold" rating on the stock in a research note on Friday, August 2nd. Evercore ISI reduced their price target on shares of Teladoc Health from $14.00 to $10.00 and set an "in-line" rating on the stock in a research report on Tuesday, July 9th. Finally, Stifel Nicolaus lowered their price objective on shares of Teladoc Health from $16.00 to $9.00 and set a "hold" rating for the company in a research report on Thursday, August 1st. Fifteen analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, Teladoc Health currently has an average rating of "Hold" and an average price target of $12.31.

Teladoc Health Stock Performance

The stock has a market capitalization of $1.50 billion, a P/E ratio of -6.17 and a beta of 0.90. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66. The stock has a 50 day simple moving average of $8.05 and a two-hundred day simple moving average of $10.95.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The business had revenue of $642.44 million during the quarter, compared to analysts' expectations of $649.34 million. On average, equities analysts forecast that Teladoc Health, Inc. will post -1.18 EPS for the current fiscal year.

Insider Activity

In related news, COO Michael Willem Waters sold 6,053 shares of Teladoc Health stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the transaction, the chief operating officer now owns 74,214 shares in the company, valued at $604,101.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Teladoc Health news, COO Michael Willem Waters sold 6,053 shares of the firm's stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $49,271.42. Following the completion of the sale, the chief operating officer now owns 74,214 shares of the company's stock, valued at approximately $604,101.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares of the company's stock, valued at $274,049.38. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 57,819 shares of company stock valued at $442,204. 0.95% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. ICA Group Wealth Management LLC bought a new position in shares of Teladoc Health during the fourth quarter worth approximately $28,000. Principal Securities Inc. bought a new stake in shares of Teladoc Health in the fourth quarter valued at about $45,000. Signaturefd LLC boosted its position in shares of Teladoc Health by 148.7% in the second quarter. Signaturefd LLC now owns 2,868 shares of the health services provider's stock valued at $28,000 after acquiring an additional 1,715 shares during the period. International Assets Investment Management LLC acquired a new position in shares of Teladoc Health in the second quarter valued at about $29,000. Finally, SageView Advisory Group LLC bought a new position in Teladoc Health during the first quarter worth about $48,000. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.